| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |